Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Tarsus Pharmaceuticals, Inc. on the deal. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company, and...
Tarsus Pharmaceuticals’ Strategic Partnership with LianBio
Amgen’s Acquisition of Rodeo Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Amgen Inc on the deal. Amgen Inc (NASDAQ:AMGN) announced its acquisition of Rodeo Therapeutics. Amgen is one of...
Cityblock Health’s $192 Million Series C-2 Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Cityblock Health on the deal. Cityblock Health, a US-based healthcare provider that caters to Medicaid and lower-income...
Pyxis Oncology’s $152M Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Pyxis Oncology on the deal. Pyxis Oncology (“Pyxis” or the “Company”) announced the closing of a $152 million...
Khatabook’s $10 Million Acquisition of Biz Analyst
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Khatabook on the deal. India-based fintech company Khatabook has acquired Biz Analyst, a software-as-a-service business management firm, in...
MaC Venture Capital’s $110 Million Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised MaC Venture Capital on the deal. MaC Venture Capital announced the formation of its $110 million inaugural fund....
Resolve Growth Partners’ Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
Resolve Growth Partners’ Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
Boston Pharma’s Llicense Arrangement with GSK
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Boston Pharma on the deal. Boston Pharma, a clinical stage biopharmaceutical company developing differentiated therapeutics, announced its strategic...
Corvus Insurance’s $100M Series C Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Corvus Insurance on the deal. Corvus Insurance, the leading provider of smart commercial insurance products powered by...
Apna.co’s $12.5 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Sequoia India, Lightspeed India and Greenoaks on the deal. Apna.co, a vertical professional networking platform, announced that...
Turntide Technologies’ Acquisition of Riptide
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Turntide Technologies on the deal. Turntide Technologies (Turntide), the company responsible for the Smart Motor System, the...